News

Sanofi and Sobi have renewed their partnership with the World Federation of Hemophilia (WFH) to support the WFH Humanitarian Aid Program for up t ...
A spontaneous hematoma reminds columnist Jennifer Lynne of the importance of taking all symptoms and bleeding seriously with hemophilia.
Hympavzi is now approved in the U.K. for the prevention of bleeds in adults and adolescents with hemophilia A or B, without ...
Hemophilia is a rare, inherited bleeding disorder in which the blood does not clot normally due to a deficiency in essential ...
Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistanceSTOCKHOLM, April 25, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) together ...
Sobi® (STO: SOBI) together with the World Federation of Hemophilia (WFH) and Sanofi, through its philanthropic organisation Foundation S, announced the signing of a contract providing support to the ...
The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi, through its philanthropic organization Foundation ...
Haemophilia patients at GMC Srinagar’s day care centre on Thursday said life saving clotting drugs remain unavailable, ...
The programs range from prevention of birth defects like spina bifida and congenital heart defects, to preventing over 30,000 people with hemophilia from suffering bleeding crises while protecting the ...
Haemophilia is a genetic disorder that impairs the bloods ability to clot normally Women with mild or severe haemophilia have ...
NNA - On the evening of Thursday, April 10, 2025, CHANCE Association successfully hosted a high-impact symposium at the Emirates Hall of the Habtoor Grand Hotel, in collaboration with the ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 ...